Cinate-500

Cinate-500 Injection contains Amikacin, a trusted aminoglycoside antibiotic that has been widely used in clinical practice for the management of serious bacterial infections. It is generally reserved for moderate to severe infections, particularly in cases where commonly used antibiotics fail to show adequate response or when resistance is suspected.In hospital and critical care settings, Cinate-500 plays an important role due to its rapid onset of action and strong bactericidal effect. It is specifically effective against a wide range of gram-negative organisms, including several multidrug-resistant strains commonly associated with complicated infections. Because of its potency, it is typically used under careful medical supervision in inpatient care.

Mechanism of Action

Amikacin exerts its antibacterial effect by directly interfering with bacterial protein synthesis. It binds irreversibly to the 30S ribosomal subunit, which disrupts the normal reading of genetic information within the bacteria. This results in the formation of abnormal proteins that are unable to function properly, ultimately leading to bacterial cell death.One of the key advantages of Amikacin is its resistance to many bacterial enzymes that usually inactivate other aminoglycosides. This makes it particularly useful in treating infections caused by resistant organisms, where treatment options are often limited.

Indications

Cinate-500 is recommended in the management of serious and complicated bacterial infections, including:

• Severe respiratory tract infections such as pneumonia
• Complicated and recurrent urinary tract infections
• Intra-abdominal infections including peritonitis
• Septicemia and other bloodstream infections
• Skin and soft tissue infections, especially in hospital settings
• Bone and joint infections
• Post-operative wound and hospital-acquired infections
• Infections caused by multidrug-resistant gram-negative bacteria

It is typically considered in cases where the infection is severe, life-threatening, or not responding adequately to first-line antibiotic therapy.

Key Benefits

• Valued in clinical practice for its dependable and rapid antibacterial activity
• Especially useful in critical care settings where timely intervention is essential
• Provides strong coverage against resistant gram-negative organisms
• Plays an important role in the management of complicated bacterial infections
• Demonstrates consistent clinical performance in hospital environments
• Widely preferred injectable antibiotic in standard hospital treatment protocols
• Trusted by physicians for managing serious systemic infections requiring fast bacterial control
• Formulated to ensure stability, reliability, and predictable therapeutic response
• Supports effective clinical outcomes in difficult-to-treat infection cases 

Dosage and Administration

Cinate-500 is administered either intramuscularly or intravenously, depending on the severity of the infection and the patient’s clinical condition.The dosage is determined strictly by the physician and is based on factors such as body weight, renal function, and severity of infection. It should always be administered under proper medical supervision in a clinical setting.During treatment, careful monitoring of kidney function and hearing ability is recommended, particularly in patients receiving prolonged therapy or higher doses, to ensure safe and effective use.

Why Choose Cinate-500?

Cinate-500 has been developed keeping in mind the growing challenge of antibiotic resistance in modern healthcare. It offers reliable therapeutic action in situations where infections are difficult to control and standard antibiotics may not be effective.Its strength lies in its consistent performance, broad antibacterial coverage, and trusted clinical history in hospital environments. Over time, it has become a dependable choice for physicians managing serious and resistant infections.In critical care practice, where accuracy, speed, and reliability matter most, Cinate-500 stands as a strong and trusted injectable antibiotic option